Yestar Healthcare Holdings Company Limited provided earnings guidance for the year ended 31 December 2023. The Group is expected to record a significant decrease in net loss of the Group to not more than approximately RMB 10 million for year 2023 as compared to the audited consolidated net loss of the Group of approximately RMB 1,021 million for the year ended 31 December 2022.
Yestar Healthcare Holdings Company Limited
Equities
2393
KYG9843W1125
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.042 HKD | -4.55% | -2.33% | -6.67% |
Apr. 26 | Yestar Healthcare Narrows Loss in 2023 | MT |
Apr. 09 | Yestar Healthcare Faces Second Arbitration Related to Trading Firm Acquisition | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.67% | 13.11M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- 2393 Stock
- News Yestar Healthcare Holdings Company Limited
- Yestar Healthcare Holdings Company Limited Provides Earnings Guidance for the Year Ended 31 December 2023